Nalidixic Acid, Oxolinic Acid, and Novobiocin Inhibit Yeast Glycyl- and Leucyl-transfer RNA Synthetases

Overview

Journal Science

Specialty Science

Date 1981 Jul 24

PMID 7017932

Citations 11

Authors

H T Wright

K C Nurse

D J Goldstein

Affiliations

Soon will be listed here.

Abstract

Nalidixic acid and novobiocin inhibit the aminoacylation and pyrophosphate exchange activities of glycyl- and leucyl-transfer RNA synthetases from bakers' yeast. Similar types of inhibition are observed for both enzymes, suggesting similar mechanisms. The potency of these inhibitors is comparable to that observed for their inhibition of in vivo DNA synthesis in eukaryotic cells.

Citing Articles

Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An Analysis.

Alexpandi R, De Mesquita J, Pandian S, Veera Ravi A Front Microbiol. 2020; 11:1796.

PMID: 32793181 PMC: 7390959. DOI: 10.3389/fmicb.2020.01796.

Adenovirus cores can function as templates in in vitro DNA replication.

Goding C, Russell W EMBO J. 1983; 2(3):339-44.

PMID: 11894947 PMC: 555138. DOI: 10.1002/j.1460-2075.1983.tb01428.x.

Rapid reversible changes in the rate of histone gene transcription and histone mRNA levels in mouse myeloma cells.

Graves R, Marzluff W Mol Cell Biol. 1984; 4(2):351-7.

PMID: 6700595 PMC: 368702. DOI: 10.1128/mcb.4.2.351-357.1984.

Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.

Sisca T, Heel R, Romankiewicz J Drugs. 1983; 25(6):544-69.

PMID: 6347618 DOI: 10.2165/00003495-198325060-00002.

Higher eukaryotic aminoacyl-tRNA synthetases in physiologic and pathologic states.

Dang C Mol Cell Biochem. 1986; 71(2):107-20.

PMID: 3534543 DOI: 10.1007/BF00214769.